Generation of metastatic variants by transfection of a rat non-metastatic epithelial cell line with genomic DNA from rat prostatic carcinoma cells

British Journal of Cancer

Volumn 77, Issue 2, 1998, Pages 287-296

  Ke, Y ^a   Beesley, C ^a   Smith, P ^a   Barraclough, R ^a   Rudland, P ^a   Foster, C S ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

DNA transfection; Dunning prostatic carcinoma cells; Metastatic phenotype; Rama 37 cell line

Indexed keywords

ANTIBIOTIC G 418; OLIGONUCLEOTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST EPITHELIUM; CANCER TRANSPLANTATION; CONTROLLED STUDY; DNA SEQUENCE; GENETIC TRANSFECTION; GENETIC VARIABILITY; MALE; METASTASIS; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROSTATE CANCER; RAT;

EID: 0031975778     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.45     Document Type: Article

References (44)

1. Ambartsumian NS, Grigorian MS, Larsen IF, Karlstrom O, Sidenius N, Rygaard J, Georgiev G and Lukanidin E (1996) Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mtsl gene. Oncogene 13: 1621-1630
2. Bao L, Loda M, Janmey PA, Stewart R, Anand-Apte B and Zetter BR (1996) Thymosin beta 15: A novel regulator of tumor cell motility upregulated in metastatic prostate cancer. Natl Med 2: 1322-1328
3. Behrend EI, Craig AM, Wilson SM, Denhardt DT and Chambers AF (1994) Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Cancer Res 54: 832-837
4. Bernstein CS and Weinberg RA (1988) Correction to expression of the metastatic phenotype in cells transfected with human metastatic tumor DNA. Proc Natl Acad USA 85: 5581-5886
5. Boring CC, Squires TS, Tong T and Montgomery S (1994) Cancer Statistics, 1994, CA-A Cancer J Clin 44: 7-26
6. Chen H, Ke Y, Oates AO, Barraclough R and Rudland PS (1997) Isolation of and the effector for metastasis-inducing DNAs from a human metastatic carcinoma cell line. Oncogene 14: 1581-1588
7. Cooper GM, Okenquist S and Silverman L (1980) Transforming activity of DNA of chemically transformed and normal cells. Nature 284: 181-188
8. Davies BR, Davies MPA, Gibbs FEM, Barraclough R and Rudland PS (1993) Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell-line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. Oncogene 8: 999-1008
9. Davies BR, Barraclough R and Rudland PS (1994) Induction of metastatic ability in a stably diploid benign rat mammary epithelial cell line by transtecfion with DNA from human malignant breast carcinoma cell lines. Cancer Res 54: 2785-2793
10. Davies MPA, Rudland PS, Robertson L, Parry EW, Jolicoeur P and Barraclough R (1996) Expression of the calcium-binding protein S100A4(p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours. Oncogene 13: 1621-1637
11. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT and Barrett JC (1995) KAI 1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 286: 884-886
12. Dunnington DJ, Hughes CM, Monaghan P and Rudl and PS (1983) Phenotypic instability of rat mammary tumor epithelial cells. J Natl Cancer Inst 71: 1227-1240
13. Dunnington DJ, Kim U, Hughes CM, Monaghan P, Ormerod J and Rudland PS (1984) Loss of myoepithelial cell characteristics in metastasizing rat mammary tumors relative to their non-metastasizing counterparts. J Natl Cancer Inst 72: 455-466
14. Feinberg AP and Vogelstein B (1983) A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6-13
15. Foster CS (1990) Predictive factors in prostatic hyperplasia and neoplasia. Hum Pathol 21: 575-577
16. Foster CS and Abel PD (1992) Clinical and molecular techniques for diagnosis and monitoring of prostatic cancer. Hum Pathol 23: 395-401
17. Gardner HAR, Berse B and Senger D (1994) Specific reduction on osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed rat 1 fibroblasts. Oncogene 9: 2321-2326
18. Gate CC, Belloni DR and Marin-Padilla M (1995) Acquisition and enhanced expression of the metastatic phenotype following transfections of genomic mouse tumor DNA containing human SCLC gene sequences. Clin Exp Met 13: 203-217
19. Glenn J, McDonald D, Horetsky RL and Sexton FM (1988) Melastatic phenotype in murine cells transfected with human DNA. J Surg Res 44: 382-390
20. Grigorian MS, Tulchinsky EM, Zain S, Ebralidze AK, Kramerov DA, Kriajevska MV, Georgiev G and Lukanidin EM (1993) The mts I gene and control of tumor metastasis. Gene 125: 229-238
21. Hayle AJ, Darling DL, Taylor AR and Train D (1993) Transfection of metastatic capability with total genomic DNA from human and mouse melastatic tumor cell-lines. Differentiation 54: 177-189
22. Ichikawa T, Ichikawa Y and Isaacs JT (1991) Genetic factors and suppression of metastatic ability of prostatic cancer. Cancer Res 51: 3788-3792
23. Isaacs JT, Isaacs WB, Feitz WFJ and Scheres J (1986) Establishment and characterization of seven Dunning rat prostatic cancer cell-lines and their use in developing methods for predicting metastatic abilities of prostatic cancer. Prostate 9: 261-281
24. Jamieson S, Barraclough R and Rudland PS (199a) Generation of metastatic variants by transfection of a non-metastatic rat mammary epithelial cell-line with DNA from metastatic rat mammary cell-lines. Pathobiology 58: 329-342
25. Jamieson S, Barraclough R and Rudland PS (1990b) Transfection of nonmetastatic diploid rat mammary epithelial cell line with the oncogenes for EJ-ras-1 and Polyoma Large T Antigen. Int J Cancer 46: 1071-1080
26. Ke Y, Jing C, Barraclough RB, Smith PH, Davies MP and Foster CS (1997) The expression of the calcium-binding protein, p9Ka, elevates as the increasing metastatic characteristics in rat prostate carcinoma cell lines. Int J Cancer 71: 832-837
27. Krontiris TG and Cooper GM (1981) Transforming activity of human-tumor DNAs. Proc Natl Acad Sci USA 78: 1181-1184
28. Land H, Parada LF and Weinberg RA (1983) Tumorigenic conversion of primary embryo fibroblasts requires at least 2 cooperating oncogenes. Nature 304: 596-602
29. Murakami YS, Brothman AR, Leach RJ and White RL (1995) Suppression of malignant phenotype in a human prostate cancer cell-line by fragments of normal chromosomal region 17q. Cancer Res 55: 3389-3394
30. Oates AJ, Barraclough R and Rudland PS (1996) The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oncogene 12: 97-104
31. Radler-Pohl A, Pohl J and Schirrmacher V (1988) Selective enhancement of metastatic capacity in mouse bladder carcinoma cells after transfection with DNA from liver metastases of human-colon carcinoma. Int J Cancer 41: 840-846
32. Reitsma PH, Rothherg PG, Astrin SM, Trial J, Barshavit Z, Hall A, Teitelnauer SI, and Kahn AJ (1983) Regulation of myc gene expression in HL-60 leukemia cells by a vitamin-D metabolite. Nature 306: 492-494
33. Sambrook J, Fritsch EF and Maniatis T (1989a) Molecular Cloning. A Laboratory Manual, 2nd edn. pp. 924-930. Cold Spring Harbor Laboratory Press: New York
34. Sambrook J, Fritsch EF and Maniatis T (1989b) Molecular Cloning. A Laboratory Manual, 2nd edn. pp. 947-958. Cold Spring Harbor Laboratory Press: New York
35. Sandberg AA (1997) Detection of chromosomal abnormalities in human prostate cancers and their pathological significance. In Pathology of the Prostate. WB Saunders: London.
36. Shin C, Shilo B, Goldford MP, Dannenberg S and Weinberg RA (1979) Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc Natl Acad Sci USA 76: 5714-5718
37. Shih C, Padhy LC, Murray M and Weinberg RA (1981) Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290: 261-264
38. Smith JR, Freije D, Carpten JD, Gronberg H, Xu J, Isaacs SD, Brownstein MJ, Bova GS, Guo H, Bujnovszky P, Nusskern DR, Damber J-E, Bergh A, Emanuelsson M, Kallioniemi OP, Walker-Daniels J, Bailey-Wilson JE, Beaty TH, Meyers DA, Walsh PC, Collins FS, Trent JM and Isaacs WB (1996) Major susceptibility locus for prostate cancer on chromosome I suggested by a genome-wide search. Science 274: 1371-1374
39. Southern PJ and Berg P (1982) Transfection of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mole Appl Genet 1: 327-341
40. Spandidos DA and Wilkie NM (1984) Expression of exogenous DNA in mammalian cells. In Transcription and Translation: A Practical Approach, Hames BD and Higgins SJ (eds), pp. 1-48. Oxford IRL Press: Oxford.
41. Van Roy FM, Messiaen L, Leibaut G, Goa J, Dragonetti CH, Fiers WC and Marcel MM (1986) Invasiveness and metastatic capability of rat fibroblast-like cells before and after transfection with immortalizing and transforming genes. Cancer Res 46: 4787-4795
42. Vousden KH, Ecceles SA, Purvies H and Marshall CJ (1986) Enhanced spontaneous metastasis of mouse carcinoma cells transfected with an activated c-Ha-ras-1 gene. Int J Cancer 37: 425-433
43. Waghorne C, Kerbel RS and Breitman ML (1987) Metastasis potential of SP1 mouse mammary adenocarcinonia cells is differentially induced by activated and normal forms of c-H-ras. Oncogene 1: 149-155
44. Wallace JS, Fleming KA and Tarin D (1988) Tumorigenic transformation of mouse NIH 3T3 cells by transfection with plasmid pSV2neo. J Pathol 156: 73-76